UNSPSC 51343008: Nevirapine hemihydrate

This classification denotes a reverse transcriptase inhibitor with the molecular formula 2C15H14N4O.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B7XF2TD73C. European Medicines Agency schedules nevirapine hemihydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB34149. Most nations, for tariff and trade purposes, schedule nevirapine hemihydrate under HS 29339940 and SITC 51577. As of Q4 2014, NEVIRAPINE HEMIHYDRATE remains US FDA's Preferred Term for this commodity.

SMILES: CC1CCNC2C1NC(=O)C3CCCNC3N2C4CC4.CC1CCNC2C1NC(=O)C3CCCNC3N2C4CC4.O.

UNSPSC 51343008 Nevirapine hemihydrate is a Commodity code that ostensibly designates a specific antiretroviral pharmaceutical, yet recent state and local procurement activity under this code shows minimal direct alignment with that narrow product scope. The recent opportunities tagged to this code encompass broader pharmaceutical procurement — including naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies, and generic multi-source pharmaceuticals through cooperative purchasing — suggesting either miscoding in source systems or use of the code as a catch-all for pharmaceutical and health-related consumables. State and local issuing bodies soliciting under or near this code include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal fire departments (City of Tampa), and multi-state cooperative purchasing alliances (Minnesota MMCAP). The work being purchased is operational pharmaceutical inventory, emergency medical supplies, and pharmaceutical sourcing infrastructure rather than a single active pharmaceutical ingredient.

Recent activity appears concentrated in Florida and Texas, with national reach through the Minnesota MMCAP cooperative purchasing vehicle serving multiple states including Oregon. Representative solicitations include Seminole County's IFB for 1,900 units of naloxone and 800 drug deactivation systems annually (IFB 60459723LAS, due July 26, 2023), the City of Tampa's sealed-bid procurement for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000 and a 5% Small Local Business Enterprise discount (26P00145, due March 13, 2026), the Texas HHS Commission's RFI regarding direct-to-manufacturer prescription programs (HHS0017013, due April 3, 2026), and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products with responses due March 26, 2026. The code shows active state and local procurement volume but limited recent opportunities tied specifically to nevirapine hemihydrate as an individual pharmaceutical product.